The cava-preserving piggyback (PB) technique requires only partial cava clamping during the anhepatic phase in liver transplantation (LT) and, therefore, maintains venous return and may hemodynamically stabilize the recipient. Hence, it is an ongoing debate whether PB implantation is more protective from acute kidney injury (AKI) after LT when compared with a classic cava replacement (CR) technique. The aim of this study was to assess the rate of AKI and other complications after LT comparing both transplant techniques without the use of venovenous bypass. We retrospectively analyzed the adult donation after brain death LT cohort between 2008 and 2016 at our center. Liver and kidney function and general outcomes including complications were assessed. Overall 378 transplantations were analyzed, of which 177 (46.8%) were performed as PB and 201 (53.2%) as CR technique. AKI occurred equally often in both groups. Transient renal replacement therapy was required in 22.6% and 22.4% comparing the PB and CR techniques (P = 0.81). Further outcome parameters including the complication rate were similar in both cohorts. Five-year graft and patient survival were comparable between the groups with 81% and 85%, respectively (P = 0.48; P = 0.58). In conclusion, both liver implantation techniques are equal in terms of kidney function and overall complications following LT.
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improvements of anesthesiologic recipient management during LT, the need for VVB has significantly decreased, despite the use of the CR technique. (8) Today, VVB is only rarely used in experienced centers.
Because it was believed that partial IVC clamping protects the liver recipient better from acute kidney injury (AKI) compared with the CR technique, numerous centers have progressively implemented the PB approach. (9) Several modified PB techniques were introduced and gained wide acceptance by transplant surgeons. (9) However, superiority of cava-preserving implantation techniques regarding the development of AKI, overall complications, and survival remains unclear. Both liver implantation techniques were performed equally often at our center. The aim of our study was therefore to compare the 2 surgical techniques without the use of a VVB in terms of AKI, overall complications, and survival after LT.
Patients and Methods

dATA COLLECTION ANd ANALYSIS
We performed a retrospective analysis of the entire adult LT cohort at our center, Royal Free Hospital, London (RFH), between April 2008 and March 2016 (Fig. 1) . LTs performed super-urgently for acute liver failure, domino and combined liver-kidney transplant, machine-perfused grafts, and retransplantations were excluded. In addition, transplant candidates with AKI or renal replacement therapy (RRT) prior to liver grafting were also excluded from our analysis (Fig. 1) . According to the surgeon's preference and anatomical or technical circumstances, PB implantation and CR techniques were almost equally used for liver engrafting. The entire set of demographic and clinical data from the donor, graft, and recipient were obtained from our prospectively maintained LT database and the center-specific electronic data system (Table 1) . Liver recipients were divided into 2 groups comparing the CR and PB implantation techniques. Additional subgroup analysis included different PB implantation techniques (side-to-side versus end-toside anastomoses) and the use of a portocaval shunt.
TECHNICAL ASPECTS FOR LIVER ImPLANTATION
Liver procurement and transport were performed according to the standard technique in our country for donation after brain death (DBD) donors. (10) At our center, the vast majority of LTs are performed by 5 consultants. The selection of the specific implantation technique was determined by the surgeon's preference (Fig. 1) .
The CR technique involves the resection of the recipient suprarenal IVC, which is associated with a complete IVC clamping and consecutive interruption of the blood circulation from the abdomen to the right heart during liver implantation time (recipient warm ischemia time or suture time). At graft implantation, the suprahepatic donor and recipient IVCs are sutured in an end-to-end fashion. An identical procedure is performed for the infrahepatic vena cava. Importantly, 2 anastomoses are necessary for IVC reconstruction. 
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In contrast, when using the cava-sparing or PB implantation technique, surgeons perform only 1 anastomosis to reconstruct the donor and recipient IVCs. During the recipient hepatectomy, all venous branches of the IVC are carefully dissected and divided between the suture or stapler ligations. In addition, the 3 main hepatic veins are prepared and either only the right or all 3 veins were closed by a stapler or by suture, according to the respective technique. Prior to liver implantation, the retrohepatic IVC of the allograft needs careful preparation on the back table. The lower cava cuff of the allograft is oversewn with a running suture or stapler. At this point, 3 different PB methods can be used to anastomose the donor and recipient IVC. At our center, mainly 2 types of reconstructions are performed.
For the side-to-side cavocavostomy, the suprahepatic and infrahepatic IVCs of the donor liver are closed with a separate running suture. The recipient IVC is partially and longitudinally clamped using a Satinsky clamp, allowing blood to recirculate from the inferior recipient body, including both kidneys toward the heart. Following a 6-8-cm cavotomy of the donor and recipient IVCs, which encompass the orifices of the 3 hepatic veins, a wide anastomosis is performed between both the donor and recipient IVCs. For the end-to-side cavocavostomy, the dorsal suprahepatic donor IVC is spatulated. A wide anastomosis is subsequently made between the spatulated suprahepatic donor IVC and the recipient IVC in an oblique end-to-side fashion, including the combined orifice of the left and middle hepatic veins. Importantly, the recipient IVC is partially clamped in a similar manner to the side-to-side PB technique using the Satinsky clamp.
At our center, a flush of the liver at the end of the cava reconstruction is routinely performed in all implantation techniques. VVB was not used for any LT. Our colleagues from anesthesia and the entire team are experienced in management during both types of cava reconstruction. Graft reperfusion was done through the portal vein first in all transplant cases in both groups.
OUTCOmE PARAmETERS
The outcome analysis included intraoperative parameters (duration of implantation and transplantation, transfusions), posttransplant liver and kidney function, intensive care unit (ICU) and hospital stay, and other complications (including vascular and biliary complications and acute rejections).
Renal function was assessed during hospital stay, at 3 and 12 months, and at 3 years after LT. To define AKI, we used the Kidney Disease: Improving Global Outcomes criteria (11) : an increase in serum creatinine by ≥26.5 µmol/L within 48 hours or an increase in serum creatinine to ≥1.5 times baseline within the first 7 days after transplantation. Additionally, 3 stages of AKI were defined: stage 1, increase ≥26.5 µmol/L or increase of 1.5-1.9-fold from baseline; stage 2, increase of 2-2.9-fold from baseline; and stage 3, increase >3-fold from baseline or increase in serum creatinine to ≥354 µmol/L or initiation of RRT.
Recipient morbidity at the end of hospital stay, after 3 months, and overall for the entire follow-up was graded by the Clavien-Dindo classification (12) and quantified using the comprehensive complication index (CCI), ranging between 0 and 100 points. (13) For example, recipients who required medical management of bleeding, infections, or slight renal dysfunction were graded as a stage II complication according to the Clavien-Dindo classification. (12) Biliary complications requiring endoscopic retrograde cholangiopancreatography (ERCP) were graded as IIIa if treatment, eg, stent placement, was needed during such ERCP. Reoperations under general anesthesia were graded as IIIb. Single-organ failure, including new RRT for severe AKI, reintubation for pulmonary failure, or readmission to ICU, was categorized as IVa grade and recipients with multiorgan failure belong to the IVb group. (12) The CCI was calculated during hospital stay, at 3 months, and overall after LT. (13) In addition, 5-year graft and patient survivals and the retransplantation rate were analyzed comparing the different implantation techniques. The median overall follow-up of our transplant recipient cohort was 1346 days (3.7 years; Table 1 ).
The posttransplantation immunosuppression regimen at our center consisted of tacrolimus, azathioprine or mycophenolate mofetil, and prednisolone, which were introduced at day 0. Prednisolone therapy was discontinued after 3 months.
Ischemic cholangiopathy was defined radiologically as intrahepatic or hilar biliary strictures and dilatations occurring in the absence of hepatic artery stenosis or hepatic artery thrombosis (HAT), portal thrombosis, chronic ductopenic rejection, and recurrent primary sclerosing cholangitis (PSC).
STATISTICAL ANALYSIS
Data are presented using the median and interquartile range (IQR) for continuous variables. The nonparametric Mann-Whitney U test was used to determine whether significant differences existed between groups. Differences in nominal data were compared by Fisher's exact test. A P value of <0.05 was deemed statistically significant. A clinical outcomes analysis was performed through Kaplan-Meier survivor plots, and significant differences between groups were assessed by log-rank/Mantel-Cox testing. Additionally, logistic regression models were fit in order to assess the impact of individual covariates on the rate of respective events (included as continuous and/or dichotomous parameters; odds ratio [OR] ). To further compare the 2 implantation techniques, we performed equivalence testing and included a noninferiority analysis for all endpoints. To demonstrate that 2 means are equivalent, the difference between the means needed to be found within the range from -25.0 to 25.0. Equivalence was demonstrated by showing that the 90% confidence interval for the difference is entirely within that range and by running 2 one-sided tests. The 2 one-sided tests established equivalence if a 90% confidence interval was included within the interval (−δ, δ; in our test, -25.0 to 25.0) with equivalence asserted given that both P values were <0.05. Noninferiority was defined as a situation where the difference between the means is not less than -25.0 (or less than -10). Noninferiority was demonstrated by showing that the 95% confidence bound satisfies the constraint and by running a one-sided test with a P value <0.05. All data were analyzed using SPSS, version 24.0 (IBM, Armonk, NY), Prism, version 5 (Graphpad, La Jolla, CA), and Statgraphics 18 (Statgraphics Technologies, The Plains, VA).
ETHICAL APPROVAL ANd QUALITY CONTROL
Completeness, plausibility, and validity of the data were independently verified (by J.D.W., M.G., A.S., and J.M.P.), including an objective review of all historical medical charts. The study protocol received a priori approval from the local institutional review committee.
Results
LT ACTIVITY ANd ImPLANTATION TECHNIQUE
Between 2008 and 2016, a total of 586 LTs were performed at our center at RFH. Livers from donation after circulatory death (DCD) donors were excluded as well as retransplantations, living donors, acute liver failures, domino transplantations, and combined liver-kidney transplantations. In addition, 7 liver recipients were not included in our analysis because of kidney injury requiring RRT prior to LT. Overall, 378 LTs were analyzed, and 201 implantations were done conventionally using the CR technique, whereas 177 livers were engrafted with the PB technique (side-toside, n = 119; end-to-side, n = 58) (Fig. 1) . The median follow-up was 1104 and 1550 days (3 years and 4.2 years; P < 0.001) for PB implants and CR transplantations, respectively (Table 1) . A total of 5% of patients (n = 10/201) in the CR group and 9% in the PB group (n = 16/177) were right lobe split grafts. Within the PB group, the majority (67.2%) used a side-to-side technique (n = 119/177). The end-to-side PB technique was used in the remaining 32.8% (n = 58/177; Supporting Table 1 ).
During the 8-year study period, the majority of the transplantations were performed by 5 consultants, independently. Although 2 consultant surgeons performed the CR technique routinely (n = 140), 1 consultant used the PB approach (n = 42). The 2 remaining consultants applied mainly PB cava reconstruction (n = 131). CR was selected by such colleagues in 42 transplant patients based on their expertise and the particular anatomical situation in the recipient, including a large segment I (Fig. 1) . To our knowledge, no changes in the implantation technique occurred in relation to the length of the suprahepatic cava vein. Portocaval shunts were used to bridge the hepatectomy in 67 of the 177 PB transplantations (37.9%; Supporting Table 1 ). Donor, graft, and recipient risk factors are shown in Table 1 . Crucial parameters, eg, donor age, donor cause of death, cold ischemia time, recipient age, recipient laboratory Model for End-Stage Liver Disease (MELD), and underlying disease were equally distributed in both groups (Table 1) . Importantly, the overall recipient risk appeared rather low in our cohort, and therefore, only a very limited number of transplant candidates had an impaired kidney function in terms of chronic kidney dysfunction at the time of surgery. This is further underlined by the median creatinine, esti- Tables 1 and 4 ). Other risk factors that may impact on kidney function after LT were distributed equally in both groups and included arterial hypertension, diabetes, portal vein thrombosis, and ascites (Table 1) .
AKI OCCURREd INdEPENdENTLY FROm THE ImPLANTATION TECHNIQUE
Liver and kidney function were comparable after LT with both types of implantation (Table 2 ; Fig. 2) . Expectedly, the CR technique resulted in a longer implantation time (recipient warm ischemia time) because such a technique requires 3-vessel anastomoses prior to liver reperfusion (compared with the PB technique with only 2 anastomoses; Table 2 ). Despite prolonged and complete cava clamping in the CR technique, the rate of AKI and RRT after LT was comparable in both groups (Table 2 ; Fig. 2 ). This is further supported by our equivalence testing, where the CR technique appeared noninferior to the PB approach in terms of kidney function and injury after LT (Supporting Figs. 2 and 3 ). AKI occurred in 14.8% of liver recipients in both groups (P > 0.99) and 22.5% of recipients required short-term RRT after PB and CR (P = 0.81). Importantly, all kidneys recovered after initial support (median RRT, 5 days; IQR, 3-12.5 days), and kidney function was comparable and stable in both groups during the follow-up period after LT ( Fig. 2 ; Supporting Tables 3A and 4). Our multivariate analysis confirmed previous results and showed that the implantation technique did not impact on the development of AKI or the need for RRT (Table 3) . In contrast, disease severity, reflected by laboratory MELD and transfusion requirement, was demonstrated to significantly impact on AKI development and the need for RRT (Table 3) .
IS THERE ANY ImPACT OF ImPLANTATION TECHNIQUE ON COmPLICATIONS ANd SURVIVAL?
Other important outcome measures during and after LT are highlighted in Table 2 . Besides the amount of transfusions and a longer implantation time in the CR group, all other outcomes were comparable. The rate of primary nonfunction (PNF), HAT, relaparotomy, the number of biopsies, and acute rejections were distributed similarly in both groups. Extrahepatic biliary strictures were found equally in both groups. All types of biliary complications were successfully treated either conservatively or through ERCP with stenting, and later reoperations were only very rarely necessary in 2 patients with early bile leak (1 in each study group). One anastomotic stricture required reoperation and performance of a hepaticojejunostomy in the PB group.
Overall complications, quantified by the ClavienDindo classification and CCI, were similar in both groups. The CCI at the end of hospital stay, after 3 months, and overall was similarly low independent of the implantation technique (in hospital, 30.8 versus 30.8 points; at 3 months, 33.5 versus 34.6 points; and overall, 39.7 versus 43.4 points; all P = not significant).
The rate of liver retransplantations (4.5% for both) and the rate of graft loss were low in both groups (15.8% versus 16.9%; P = 0.78; Table 2 ). Five-year patient and graft survival rates were equally good in both cohorts (Fig. 3) . 
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IS THERE ANY ImPACT ON OUTCOmES AFTER LT REGARdING THE TYPE OF PB ImPLANTATION TECHNIQUE?
Despite the significantly longer duration of LT in end-to-side PB implantations (7.1 versus 5.8 hours; P < 0.001), liver recipients transplanted with both cava-preserving techniques performed equally well during and after LT (Supporting Tables 1 and 2B ). AKI and all other complications occurred equally often during follow-up. Graft and patient survival rates were excellent in both groups (Supporting Fig. 1 ).
Discussion
Which implantation technique protects best from AKI after LT is an ongoing debate. Here, we provide a detailed analysis on the development of AKI, overall complications, and survival after LT when comparing CR and PB implantation techniques without the use of VVB in a comprehensive single-center environment. First, we demonstrate that AKI occurred independently from the implantation technique. Second, we show that none of the most frequently used implantation techniques specifically impact on other complications. Third, we found no difference in outcomes when comparing modified side-to-side with end-to-side PB techniques for engrafting. And finally, the overall graft and patient survival rates were equally good after 5 years when comparing such different implantation techniques. To date, no profound analyses have convincingly shown superiority of 1 surgical technique regarding outcome measures after LT including AKI. In order to protect the liver recipient from profound hypotension during the anhepatic phase with consecutive kidney injury, VVB was initially thought to be always required when CR techniques with total IVC and portal vein clamping were used for LT. (2) However, reliable data analyses from larger transplant cohorts are still lacking. To our knowledge, only 1 randomized controlled trial specifically analyzed the impact of VVB on kidney injury after LT using the CR technique. This trial was reported by Grande et al. in 1996 and involved only 39 recipients in each arm. The results paralleled our findings, and the authors demonstrated that the use of VVB did not protect the kidneys from the development of AKI after LT. (14) Importantly, this trial was performed by a group of anesthetists and explored cardiac output and cava pressures in detail. The authors demonstrated that venous blood is insufficiently drained from the lower body compartment, including both kidneys despite the use of VVB. (14) A recently published large retrospective study showed that the use of VVB during LT with the CR technique did not protect from posttransplant AKI in patients with normal pretransplant renal function, and VVB was even negatively associated with the development of AKI. (15) In addition, several smaller retrospective studies analyzed the impact of VVB on dynamic stability in the setting of PB implantation. (7, 16) Interestingly, the majority of authors reported superiority of PB implantation without the use of VVB. (6) In this context, the initially attributed advantages using the VVB became less valid today, mainly because surgical and anesthesiologic techniques have significantly improved. For example, specific pressure measurements in both circulatory systems are used to assess the optimal volume status, which substantially decreased the need for VVB to achieve hemodynamic stability of liver recipients during graft implantation. In addition, a general avoidance strategy for the use of nephrotoxic drugs has resulted in a decreased rate of postoperative AKI, despite increasing overall recipient risk in the MELD era. (17) Moreover, with a complication rate of up to 30%, VVB has also significant disadvantages and physicians aim to avoid air and thromboembolisms as the most feared complications. (18) Such developments have overall led to technical modifications and impacted on the choice of surgical transplantation techniques in each center. (5) Today, only very few transplant centers routinely use VVB for classic CR implantation. (18) In this context, we were interested to explore outcomes after LT comparing different implantation techniques without the use of VVB. With almost 600 LTs in an 8-year period, our team has gained a reasonable experience in this field when compared with other well-known transplant units in the United Kingdom. Our general outcomes meet recently published benchmark values for primary LTs. (19) Importantly, liver recipients in each implantation group achieved such thresholds, eg, short ICU and hospital stay, low overall complications, and excellent 5-year survival rates. In addition, we did not demonstrate that 1 of the 2 implantation techniques was superior in terms of kidney function, despite total IVC clamping in the CR group. These results may be based on general technical improvements and an overall rather short IVC clamping time of 43 minutes in our cohort of CR transplantations. Our findings parallel previous reports where the implantation technique did not impact on kidney function given the total IVC clamping time was shorter than 70 minutes in liver recipients with normal renal function prior to LT. (20) The implementation of the PB technique was always related to the idea to prevent IVC clamping, to maintain venous backflow, and to reduce the necessity of VVB, which is also known to induce a certain hemodynamic recipient instability. (21) Total cava clamping and the consecutive interruption of blood outflow from the inferior body including the kidneys has been discussed as a crucial intraoperative risk factor of AKI development after LT. (22, 23) However, general data are scarce, and our results did not support such historical ideas.
Because of the exclusion of acute liver failures, retransplantations, DCD liver grafts, and recipients with known severe kidney injury, we created a transplant cohort with an overall lower risk and were therefore able to assess the specific impact of the implantation technique on AKI and other outcomes. In our cohort, the development of AKI was significantly related to the disease severity of the liver recipient, reflected by the laboratory MELD and the amount of transfusions required during LT. In this context, our findings parallel previously published outcomes reported by Romano et al., which showed that the recipient laboratory MELD significantly impacts on the development of AKI after LT. (24) Notably, in the United Kingdom, the general recipient risk, presented by the median laboratory MELD of 16 points in our cohort of chronic liver disease, appears lower compared with
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the United States or other European countries. Our analysis enabled us, therefore, to assess the impact of the 2 surgical approaches in a homogeneous cohort of liver recipients with overall good kidney function at the time of LT. The amount of transfused red blood cell (RBC) concentrates is both also related to the disease severity of the recipient and represents the complexity of the transplantation surgery being a surrogate marker for intraoperative bleeding and intermittent hypotension. Both features were previously shown to induce AKI after major surgeries and transplantation. (24, 25) The choice of transplantation technique in each center depends on several factors, eg, which technique has a profound tradition, the surgeon's preferences, anatomical variations, graft size, and the experience of the entire team. (26) At our center, 5 independent surgeons have their particular preferences applying both techniques, and only in a few cases is an individual decision made to adapt to certain anatomical conditions. Our team of anesthetists is therefore experienced to adapt to the specific circumstances of each recipient. For both the CR approach and the PB technique, the central venous pressure is suggested to be kept low (27) to protect from significant blood loss. In addition, special anesthesia management for CR includes higher-volume supplementation prior to implantation and potential higher inotrope requirements to maintain recipient blood pressures during IVC clamping. (26) In this context, not only surgeon's preferences but also center policy are of utmost importance when choosing the right implantation technique. Although the ability to quickly implement a VVB might be of benefit in the setting of LT and other difficult hepatic resections, our results have confirmed that the routine use of bypass is not required. Moreover, CR technique was previously shown to result in excellent outcomes without the need for VVB in high MELD cohorts by many. (28, 29) Our study also has several limitations such as the retrospective design. However, such a comprehensive, single-center environment might also be beneficial because confounding factors are potentially reduced and assessment of the specific impact of implantation techniques appears feasible. The lack of high-MELD candidates in our cohort enabled us to compare the impact of the different implantation techniques on outcome and the development of kidney injury. Although randomized comparisons are not available, previous studies have demonstrated the safety of the CR technique in high-risk LT candidates with the expected high morbidity but equal overall recovery of kidney function and survival compared with low-risk and low-MELD candidates. (29) In conclusion, we have demonstrated that both liver implantation techniques, PB implantation and CR, are well received and achieve equal outcomes after transplantation. Importantly, AKI and overall complications did not occur more frequently when the classic CR technique was used. The final decision of which technical approach is applied depends on the personal preferences of the implanting surgeon, the center's strategy, and may also change during the operation given certain anatomical variations in the donor liver and the recipient.
